KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Inventory Average (2018 - 2026)

Aquestive Therapeutics has reported Inventory Average over the past 8 years, most recently at $7.0 million for Q4 2025.

  • For Q4 2025, Inventory Average rose 7.56% year-over-year to $7.0 million; the TTM value through Dec 2025 reached $7.0 million, up 7.56%, while the annual FY2025 figure was $6.1 million, 4.68% down from the prior year.
  • Inventory Average for Q4 2025 was $7.0 million at Aquestive Therapeutics, down from $8.0 million in the prior quarter.
  • Over five years, Inventory Average peaked at $8.0 million in Q3 2025 and troughed at $2.6 million in Q1 2021.
  • A 5-year average of $5.8 million and a median of $6.5 million in 2023 define the central range for Inventory Average.
  • Biggest five-year swings in Inventory Average: decreased 11.54% in 2021 and later soared 105.77% in 2022.
  • Year by year, Inventory Average stood at $3.5 million in 2021, then soared by 81.21% to $6.3 million in 2022, then rose by 10.74% to $6.9 million in 2023, then fell by 5.65% to $6.5 million in 2024, then rose by 7.56% to $7.0 million in 2025.
  • Business Quant data shows Inventory Average for AQST at $7.0 million in Q4 2025, $8.0 million in Q3 2025, and $7.7 million in Q2 2025.